{"transactions":[{"id":758453,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2026-05-29T21:01:22.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":64609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."}],"balance_after":291479,"source":{"system":"sec-edgar","filing":"0001171843-26-003801","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003801/ownership.xml","form_type":"4"}},{"id":848271,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2026-03-11T21:02:18.000Z","date":"2026-02-26","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.57,"value":3140.0,"ownership":{"direct":true},"balance_after":226870,"source":{"system":"sec-edgar","filing":"0001171843-26-001490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001490/ownership.xml","form_type":"4"}},{"id":1127246,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2025-06-03T01:18:41.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":207201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 142,592 shares shall vest in equal proportions over eighteen (18) months, commencing on the grant date and (ii) 64,609 shares vest in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 142,592 shares shall vest in equal proportions over eighteen (18) months, commencing on the grant date and (ii) 64,609 shares vest in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023."}],"balance_after":224870,"source":{"system":"sec-edgar","filing":"0001171843-25-003587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003587/ownership.xml","form_type":"4"}},{"id":1814705,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2023-08-04T20:18:59.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":93200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units (\"RSUs\"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2022. The number of RSUs was determined by dividing such portion of the cash bonus by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023."}],"balance_after":123680,"source":{"system":"sec-edgar","filing":"0001654954-23-010167","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423010167/section16.xml","form_type":"4"}},{"id":1824011,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:46:08.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":80000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001654954-23-009601","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009601/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824674,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:31:08.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":80000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001654954-23-009533","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009533/section16.xml","form_type":"4"}},{"id":2124184,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T19:27:10.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":2119,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."}],"balance_after":2119,"derivative":{"exercise_price":1,"underlying":"Common Shares","underlying_shares":2119},"source":{"system":"sec-edgar","filing":"0001654954-22-014747","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014747/section16.xml","form_type":"4"}},{"id":2124183,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T19:27:10.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":2119,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."}],"balance_after":2119,"derivative":{"exercise_price":1.5,"underlying":"Common Shares","underlying_shares":2119},"source":{"system":"sec-edgar","filing":"0001654954-22-014747","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014747/section16.xml","form_type":"4"}},{"id":2124182,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2022-11-04T19:27:10.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":4239,"price":1.125,"value":4768.875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."}],"balance_after":30480,"source":{"system":"sec-edgar","filing":"0001654954-22-014747","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014747/section16.xml","form_type":"4"}},{"id":2218511,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2022-06-30T15:23:43.000Z","date":"2022-06-29","kind":"purchase","acquired":true,"shares":3000,"price":1.4943,"value":4482.9,"ownership":{"direct":true},"balance_after":26241,"source":{"system":"sec-edgar","filing":"0001654954-22-009005","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422009005/section16.xml","form_type":"4"}},{"id":2224975,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2022-06-21T12:30:34.000Z","date":"2022-06-16","kind":"purchase","acquired":true,"shares":3000,"price":1.6055,"value":4816.5,"ownership":{"direct":true},"balance_after":23241,"source":{"system":"sec-edgar","filing":"0001654954-22-008536","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422008536/section16.xml","form_type":"4"}},{"id":2254918,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2022-05-26T16:29:28.000Z","date":"2022-05-25","kind":"purchase","acquired":true,"shares":3500,"price":1.74,"value":6090.0,"ownership":{"direct":true},"balance_after":20241,"source":{"system":"sec-edgar","filing":"0001654954-22-007559","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422007559/section16.xml","form_type":"4"}},{"id":2332746,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2022-03-15T16:44:27.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":1250,"price":2.7893,"value":3486.625,"ownership":{"direct":true},"balance_after":16741,"source":{"system":"sec-edgar","filing":"0001654954-22-003144","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422003144/section16.xml","form_type":"4"}},{"id":2337234,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Shares","published_at":"2022-03-11T16:10:43.000Z","date":"2022-03-10","kind":"purchase","acquired":true,"shares":1000,"price":3.2229,"value":3222.9,"ownership":{"direct":true},"balance_after":15491,"source":{"system":"sec-edgar","filing":"0001654954-22-002936","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422002936/section16.xml","form_type":"4"}},{"id":2341220,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Shares","published_at":"2022-03-09T16:06:00.000Z","date":"2022-03-08","kind":"purchase","acquired":true,"shares":1250,"price":2.8975,"value":3621.875,"ownership":{"direct":true},"balance_after":14491,"source":{"system":"sec-edgar","filing":"0001654954-22-002765","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422002765/section16.xml","form_type":"4"}},{"id":2347192,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-08T00:40:28.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":43500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":43500,"derivative":{"exercise_price":3.71,"expiration_date":"2032-02-28","underlying":"Common Shares","underlying_shares":43500},"source":{"system":"sec-edgar","filing":"0001654954-22-002653","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422002653/section16.xml","form_type":"4"}},{"id":2739374,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T21:00:04.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":80000,"derivative":{"exercise_price":5.45,"expiration_date":"2031-04-22","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001654954-21-004632","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495421004632/section16.xml","form_type":"4"}},{"id":2770282,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Shares","published_at":"2021-03-26T15:44:02.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":3500,"price":5.19,"value":18165.0,"ownership":{"direct":true},"balance_after":13241,"source":{"system":"sec-edgar","filing":"0001654954-21-003333","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495421003333/section16.xml","form_type":"4"}},{"id":2771685,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common stock","published_at":"2021-03-25T18:56:47.000Z","date":"2021-03-24","kind":"purchase","acquired":true,"shares":4500,"price":5.08,"value":22860.0,"ownership":{"direct":true},"balance_after":9741,"source":{"system":"sec-edgar","filing":"0001654954-21-003279","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495421003279/section16.xml","form_type":"4"}},{"id":2988000,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-11-09T20:39:22.000Z","date":"2020-11-06","kind":"other","acquired":false,"shares":914,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":914},"source":{"system":"sec-edgar","filing":"0001654954-20-012001","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420012001/section16.xml","form_type":"4"}},{"id":2987999,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-11-09T20:39:22.000Z","date":"2020-11-06","kind":"other","acquired":true,"shares":914,"price":4,"value":3656.0,"ownership":{"direct":true},"balance_after":5241,"source":{"system":"sec-edgar","filing":"0001654954-20-012001","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420012001/section16.xml","form_type":"4"}},{"id":3006848,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Stock option (right to buy)","published_at":"2020-10-14T19:57:10.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":50000,"derivative":{"exercise_price":7.44,"expiration_date":"2030-10-13","underlying":"Common shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001654954-20-011151","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420011151/section16.xml","form_type":"4"}},{"id":3130176,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-05-29T13:20:07.000Z","date":"2020-05-27","kind":"purchase","acquired":true,"shares":1000,"price":3,"value":3000.0,"ownership":{"direct":true},"balance_after":4327,"source":{"system":"sec-edgar","filing":"0001654954-20-006075","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420006075/section16.xml","form_type":"4"}},{"id":3130175,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-05-29T13:20:07.000Z","date":"2020-05-27","kind":"purchase","acquired":true,"shares":1500,"price":2.999,"value":4498.5,"ownership":{"direct":true},"balance_after":3327,"source":{"system":"sec-edgar","filing":"0001654954-20-006075","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420006075/section16.xml","form_type":"4"}},{"id":3270031,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Share Option (Right to Buy)","published_at":"2020-02-14T23:19:56.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":68988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested"}],"balance_after":68988,"derivative":{"exercise_price":3.16,"expiration_date":"2030-02-12","underlying":"Common Shares","underlying_shares":68988},"source":{"system":"sec-edgar","filing":"0001654954-20-001654","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420001654/section16.xml","form_type":"4"}},{"id":3312355,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-13T13:31:29.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":914,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Amended to reflect acquisition from the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,827 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":914,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":914},"source":{"system":"sec-edgar","filing":"0001654954-20-000338","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000338/section16.xml","form_type":"4/A","original_submission_date":"2020-01-10"}},{"id":3312354,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-13T13:31:29.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":1371,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Amended to reflect acquisition from the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,827 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":1371,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":1371},"source":{"system":"sec-edgar","filing":"0001654954-20-000338","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000338/section16.xml","form_type":"4/A","original_submission_date":"2020-01-10"}},{"id":3312353,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-01-13T13:31:29.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":1827,"price":4.11,"value":7508.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Amended to reflect acquisition from the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,827 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":1827,"source":{"system":"sec-edgar","filing":"0001654954-20-000338","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000338/section16.xml","form_type":"4/A","original_submission_date":"2020-01-10"}},{"id":3313094,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T19:09:07.000Z","date":"2020-01-08","kind":"purchase","acquired":true,"shares":914,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,371 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":914,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":914},"source":{"system":"sec-edgar","filing":"0001654954-20-000265","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000265/section16.xml","form_type":"4"}},{"id":3313093,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T19:09:07.000Z","date":"2020-01-08","kind":"purchase","acquired":true,"shares":1371,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,371 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":1371,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":1371},"source":{"system":"sec-edgar","filing":"0001654954-20-000265","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000265/section16.xml","form_type":"4"}},{"id":3313092,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-01-10T19:09:07.000Z","date":"2020-01-08","kind":"purchase","acquired":true,"shares":1827,"price":4.11,"value":7508.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,371 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":1827,"source":{"system":"sec-edgar","filing":"0001654954-20-000265","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000265/section16.xml","form_type":"4"}},{"id":3452997,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T22:31:22.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":91,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents additional options to purchase common stock of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the \"Issuer\") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. (\"Edesa\"), and the shareholders of Edesa.  The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders.  This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"shares","element":"transactionShares","label":"F3","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option vests and becomes exercisable 1/3 on December 28, 2019, and monthly thereafter through December 28, 2021."}],"balance_after":1620,"derivative":{"exercise_price":2.16,"expiration_date":"2028-12-28","underlying":"Common Shares","underlying_shares":91},"source":{"system":"sec-edgar","filing":"0001779126-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177912619000003/primary_doc.xml","form_type":"4"}},{"id":3452996,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T22:31:22.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":1365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents additional options to purchase common stock of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the \"Issuer\") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. (\"Edesa\"), and the shareholders of Edesa.  The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders.  This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"shares","element":"transactionShares","label":"F3","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests and becomes exercisable 1/3 on September 26, 2018, and monthly thereafter through September 26, 2020."}],"balance_after":24299,"derivative":{"exercise_price":2.16,"expiration_date":"2027-09-26","underlying":"Common Shares","underlying_shares":1365},"source":{"system":"sec-edgar","filing":"0001779126-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177912619000003/primary_doc.xml","form_type":"4"}},{"id":3452995,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T22:31:22.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":7663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents additional options to purchase common stock of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the \"Issuer\") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. (\"Edesa\"), and the shareholders of Edesa.  The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders.  This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"shares","element":"transactionShares","label":"F3","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested on August 28, 2017."}],"balance_after":136416,"derivative":{"exercise_price":2.16,"expiration_date":"2027-08-28","underlying":"Common Shares","underlying_shares":7663},"source":{"system":"sec-edgar","filing":"0001779126-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177912619000003/primary_doc.xml","form_type":"4"}},{"id":3493758,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T00:22:02.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":1529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 7, 2019, Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) completed its share exchange transaction with Edesa Biotech Inc. (\"Edesa\") and the shareholder of Edesa pursuant to that certain Share Exchange Agreement, dated March 7, 2019.  This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"shares","element":"transactionShares","label":"F3","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option vests and becomes exercisable 1/3 on 12/28/19, and monthly thereafter through 12/28/21."}],"balance_after":1529,"derivative":{"exercise_price":0.38,"expiration_date":"2028-12-28","underlying":"Common Shares","underlying_shares":1529},"source":{"system":"sec-edgar","filing":"0001779126-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177912619000002/primary_doc.xml","form_type":"4"}},{"id":3493757,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T00:22:02.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":22934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 7, 2019, Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) completed its share exchange transaction with Edesa Biotech Inc. (\"Edesa\") and the shareholder of Edesa pursuant to that certain Share Exchange Agreement, dated March 7, 2019.  This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"shares","element":"transactionShares","label":"F3","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests and becomes exercisable 1/3 on 9/26/18, and monthly thereafter through 9/26/20."}],"balance_after":22934,"derivative":{"exercise_price":0.38,"expiration_date":"2027-09-26","underlying":"Common Shares","underlying_shares":22934},"source":{"system":"sec-edgar","filing":"0001779126-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177912619000002/primary_doc.xml","form_type":"4"}},{"id":3493756,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T00:22:02.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":128753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 7, 2019, Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) completed its share exchange transaction with Edesa Biotech Inc. (\"Edesa\") and the shareholder of Edesa pursuant to that certain Share Exchange Agreement, dated March 7, 2019.  This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"shares","element":"transactionShares","label":"F3","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested on 8/28/17."}],"balance_after":128753,"derivative":{"exercise_price":0.38,"expiration_date":"2027-08-28","underlying":"Common Shares","underlying_shares":128753},"source":{"system":"sec-edgar","filing":"0001779126-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177912619000002/primary_doc.xml","form_type":"4"}}]}